Virtu Financial LLC Invests $244,000 in Masimo Co. (NASDAQ:MASI)

Virtu Financial LLC bought a new stake in Masimo Co. (NASDAQ:MASI) in the 4th quarter, Holdings Channel.com reports. The fund bought 1,478 shares of the medical equipment provider’s stock, valued at approximately $244,000.

Several other large investors have also recently added to or reduced their stakes in MASI. Northwest & Ethical Investments L.P. acquired a new position in Masimo in the fourth quarter valued at $116,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Masimo by 0.8% during the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,815 shares of the medical equipment provider’s stock worth $1,622,000 after purchasing an additional 82 shares during the last quarter. Harvest Fund Management Co. Ltd raised its position in shares of Masimo by 339.2% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 3,891 shares of the medical equipment provider’s stock valued at $656,000 after purchasing an additional 3,005 shares in the last quarter. Xponance Inc. boosted its stake in shares of Masimo by 4.4% during the 4th quarter. Xponance Inc. now owns 7,025 shares of the medical equipment provider’s stock valued at $1,161,000 after buying an additional 299 shares during the last quarter. Finally, Advisors Asset Management Inc. grew its position in shares of Masimo by 61.6% during the fourth quarter. Advisors Asset Management Inc. now owns 22,974 shares of the medical equipment provider’s stock worth $3,798,000 after buying an additional 8,758 shares in the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MASI has been the subject of several research analyst reports. Wells Fargo & Company boosted their target price on shares of Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Raymond James increased their target price on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research report on Friday, December 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Wednesday, February 26th. Finally, Piper Sandler lifted their price objective on shares of Masimo from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Masimo presently has a consensus rating of “Moderate Buy” and a consensus target price of $194.80.

Insider Activity

In related news, Director Craig B. Reynolds sold 2,053 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the transaction, the director now owns 16,581 shares in the company, valued at approximately $2,754,601.53. This represents a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Bilal Muhsin sold 30,000 shares of the firm’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the transaction, the chief operating officer now owns 24,172 shares in the company, valued at $4,048,568.28. This represents a 55.38 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by corporate insiders.

Masimo Stock Down 2.9 %

MASI stock opened at $163.55 on Friday. Masimo Co. has a 12 month low of $101.61 and a 12 month high of $194.88. The firm has a 50 day simple moving average of $174.79 and a 200 day simple moving average of $161.06. The firm has a market cap of $8.82 billion, a PE ratio of 112.79 and a beta of 1.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $600.70 million during the quarter, compared to analyst estimates of $593.35 million. Equities research analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.